Results 71 to 80 of about 23,073,058 (182)

A multinational pharmacoeconomic analysis of oral therapies for onychomycosis

, 1994
Arikian SR, Einarson TR, Kobeltnguyen G, et al. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. British Journal of Dermatology. 1994;130(Suppl.
Gunn, D, Stubb, S, Tosti, A, Camarasa, JMG, Feuilhade, M, Knappe, E, Lucioni, C, Mathioudaki, E, Van Doorstaer, E, Roberts, DT, Van Hecke, E, Rey, JP, Arikian, SR, Rutten, F, Baran, R, Einarson, TR, De Cuyper, C, Hannuksela, M, Gisbert, R, Pereira, J, Soares, AP, Germaine, GERMAINE, Havu, V, Eichmann, A, Spangler, E, Koussidou- Eremonti, T, Kobeltnguyen, G, Panagiotidou, D, Rovira, J, Zalinski, J, Groeneweg, DA, Bergman, W, Difonzo, E, Lee, RE, Bitetto, L, Ginter, G, Doyle, JJ, Rufli, T, Stavropoulos, P, Figueiredo, A, Flori, YA, Stavrianeas, N, Effendy, Isaak ; https://orcid.org/, Clement, W, Goodfield, M, Topolewski, K, Lateur, N, Yfantopoulos, J, Pirard, C, Schubert, F, Sommer, JH, Allen, R, Nolting, S, Taddio, A, Vareltzidis, A, Pietrini, P, Vagena, A, Blattstein, JS, Mikultis, R, Pekurinen, M, Breda, M, Stary, A   +61 more
core   +1 more source

Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers

Фармакоэкономика, 2019
Aim: to assess the socio-economic burden of smoking in the Russian Federation for 2017.Materials and methods. The socio-economic burden was calculated and extrapolated to the entire population of smokers in Russia and then compared with equal sized ...
E. V. Radchenko, A. S. Kolbin
doaj   +1 more source

Artificial Intelligence‐Driven Precision Bisphosphonate Therapy in Osteoporosis: Mechanisms, Clinical Applications, Risks, and Future Directions

Orthopaedic Surgery, EarlyView.
This comprehensive review integrates 17 benchmark studies to illustrate the transition of osteoporosis management toward precision medicine. The schematic highlights three key clinical applications: AI‐driven opportunistic screening from routine CTs, precision pharmacotherapy selection, and the predictive prevention of adverse events like MRONJ ...
Xiang Yao, Yicong Chao, Xiao Gu, Jingtao Peng, Jishan Yuan, Wei Shi, Fuguo Zhang, Qiwen Bao   +7 more
wiley   +1 more source

Budget impact of implementing universal Plasmodium NAT screening in the blood transfusion system in the US

Transfusion, EarlyView.
Abstract Background Blood donor deferral for malaria risk relies exclusively on responses to self‐reported questionnaires. This study evaluated the economic impact of introducing Plasmodium nucleic acid testing (NAT) as a universal screening strategy in the United States.
Cristina Coll‐Ortega, Elisabet Viayna, Jiani Zhou, Susan L. Stramer   +3 more
wiley   +1 more source

Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients

Фармакоэкономика, 2017
Recently, an increase in the incidence of severe forms of prostate cancer, in particular castration-resistant prostate cancer (CRPC) has been noticed.
N. K. Mazina, P. V. Mazin
doaj   +1 more source

Global Landscape and Thematic Evolution of Selective GLP‐1 Receptor Agonists and GLP‐1–Based Multi‐Receptor Agonists in Type 2 Diabetes Mellitus: A Bibliometric Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
Bibliometric analysis of 3736 publications (2004–2025) reveals rapid growth in GLP‐1–based T2DM research. The US leads, with Novo Nordisk and Eli Lilly as top contributors. Thematic shifts from glycemic control toward cardiovascular‐kidney‐metabolic outcomes and real‐world evidence, driven by landmark trials like LEADER and REWIND.
Yanbing Wang, Zhanru Liu, Shifeng Wang, Cuiyan Lv, Hesham R. El‐Seedi, Shaden A. M. Khalifa, Haiyan Wang   +6 more
wiley   +1 more source

REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS [PDF]

, 2015
Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation.
Roman Andreevich Gapeshin, Aleksei Sergeevich Kolbin, Andrey Vladislavovich Pavlysh, Stanislav Mikhailovich Malyshev   +3 more
core   +1 more source

Patient‐Journey Mapping of CIDP Management in the Philippines: A Survey‐Informed Expert Panel Study and Recommendations From Treat CIDP Philippine Working Group

Clinical and Experimental Neuroimmunology, Volume 17, Issue 4, November 2026.
ABSTRACT Objectives To characterize real‐world barriers to chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) management in the Philippines and identify pragmatic patient‐centered solutions aligned with international guidance and local health‐system realities. Methods We conducted a survey‐informed qualitative expert‐panel study involving
Raymond L. Rosales, Bibek Gyanwali, Mario B. Prado Jr, Ma. Geraldine S. Espiritu, Paul Matthew D. Pasco, Joh Aldwin Uy Co, Steven Gayoles Villaraza   +6 more
wiley   +1 more source

Development of the Japanese Version of the Alzheimer's Disease Cooperative Study—Activities of Daily Living in Mild Cognitive Impairment Scale

Psychogeriatrics, Volume 26, Issue 6, November 2026.
ABSTRACT Background Assessment scales to detect subtle declines in activities of daily living (ADL) among patients with mild cognitive impairment (MCI) are needed for early diagnosis and support. This study examined the psychometric properties of the Japanese version of the Alzheimer's Disease Cooperative Study‐Activities of Daily Living for Mild ...
Daiki Ishimaru, Maki Suzuki, Hideki Kanemoto, Kunihiko Katsuki, Yuma Nagata, Natsuho Hirakawa, Daiki Taomoto, Yuto Satake, Rei Takahashi, Kazue Shigenobu, Kenji Yoshiyama, Manabu Ikeda   +11 more
wiley   +1 more source

Pharmacoeconomic analysis of parenteral therapy consumption in hospital pharmacy at Clinical Hospital – Stip [PDF]

, 2022
Improper management of drugs and medical devices is a complex problem at all health care levels. A study conducted in 2016 in which were included 35 hospitals in Poland (Religioni, 2016), was the basis for developing a drug management system.
Stefanovska, Tamara, Mihailova, Lidija, Drakalska, Elena, Lazarova, Biljana, Angelovska, Bistra   +4 more
core